Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Caris Precision Oncology Alliance Partners with the National Cancer Institute, Part of the National Institutes of Health, to Expand Collaborative Clinical Research Efforts
Caris Life Sciences® (Caris), a molecular science company developing and delivering technologies to revolutionize healthcare, announced […]
Code Ocean Selected by Lantern Pharma to Power A.I. and Computational Biology Research & Data-Driven Oncology Drug Development Collaborations
Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform […]
BHF Teams Up With The Francis Crick Institute to Bolster Cardiovascular Research
BHF have teamed up with the Francis Crick Institute to improve understanding of cardiovascular health […]
Aktana Acquires Ople.AI’s Machine Learning Automation Technology
Aktana, the leader in intelligent customer engagement for the global life sciences industry, today announced […]
Koa Health Bolsters UK Leadership Team Appointing First UK Commercial Director as Business Grows
Koa Health, a digital mental healthcare provider offering personalized mental health solutions backed by science, […]
Sphere Fluidics Closes a $40 Million Funding Round Led by Sofinnova Partners and Redmile Group
Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned […]
SCIENION & Cellenion Launch spheroONE ®, a Large-Particle Sorter and Dispenser to Advance Drug Testing on Complex In-Vitro 3D Models
Today, SCIENION & Cellenion, BICO companies, announced the launch of spheroONE, an innovative single large-particle sorter and dispenser which will […]
Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious […]
Bicycle Therapeutics Announces Expansion of Genentech Immuno-Oncology Collaboration
Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics […]
Quell Therapeutics Granted CTA Approval to Begin First Clinical Trial with a Multi-modular Engineered Treg Cell Therapy
Quell Therapeutics Ltd (“Quell“), the world leader in developing engineered T-regulatory (Treg) cell therapies for […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more